Drugs in the Pipeline Denosumab Biosimilar for Osteoporosis, Other Conditions Under FDA Review By Diana Ernst, RPh Publish Date February 6, 2023
Drugs in the Pipeline January 2023 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date February 1, 2023
Drugs in the Pipeline Belimumab Granted Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date February 1, 2023
News Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor By Brian Park, PharmD Publish Date February 1, 2023
News Amjevita, a Biosimilar to Humira, Now Available By Brian Park, PharmD Publish Date January 31, 2023
News High-Dose Exercise No Better Than Low-Dose Exercise for Knee Osteoarthritis Publish Date January 26, 2023
News Aspirin Noninferior to Low-Molecular-Weight Heparin After Fracture Publish Date January 23, 2023
Drugs in the Pipeline Antibody Oligonucleotide Conjugate Fast Tracked for Facioscapulohumeral Muscular Dystrophy By Brian Park, PharmD Publish Date January 18, 2023
News Prostate Cancer ADT Increases Bone Fracture Risk By Jody A. Charnow Publish Date January 17, 2023
Drugs in the Pipeline Vamorolone Under Review for Duchenne Muscular Dystrophy By Brian Park, PharmD Publish Date January 10, 2023
News ACP Updates Living Guideline on Pharmacologic Treatment of Osteoporosis Publish Date January 4, 2023
News Best Diets According to the Experts: 2023 Rankings Revealed By Steve Duffy Publish Date January 3, 2023
News Idacio, a Citrate-Free Biosimilar to Humira, Gets FDA Approval By Brian Park, PharmD Publish Date December 19, 2022
Drugs in the Pipeline November 2022 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date December 8, 2022